Regions
China logistics robotics player Geek+ raises $100m
China’s Geek+, a manufacturer of robots used to move merchandise around warehouses, has raised USD 100m in Series E funding at a valuation of about USD 2bn.
Hong Kong's Gly Capital closes debut mobility fund
Gly Capital Management, which is majorly owned by a Chinese automaker, tapped external investors for the first time in raising USD 163m for global investments in smart cities and smart cars
Fund focus: Insignia takes two months to scale up
Insignia Venture Partners received subscriptions to its third fund amounting to twice the size of the final corpus, underlining the appeal of Southeast Asia. The GP is keen to leverage China’s talent exodus
Deal focus: Allegro pumps up in New Zealand
Australia’s Allegro Funds has made its first investment from its largest fund to date, flexing new capacity to invest at scale with petrol station chain Gull New Zealand
Profile: Anil Ahuja
After pioneering Indian private equity and helping launch some of the biggest movers and shakers in the region, Anil Ahuja called it quits. In some ways, the postscript has been more rewarding
Asia agtech: Work in progress
Global food supply issues and local economic realities are driving more capital into Asia’s agricultural technology space, where business models – from marketplaces to deep-tech – are still being proven
China's Black Sesame completes Series C with $500m haul
Black Sesame Technologies, a China-based chipmaker specializing in autonomous driving applications, has closed a Series C extension led by SummitView Capital. This brings the size of the overall round to USD 500m.
J-Star invests in Japanese courier business
Japanese lower middle-market private equity firm J-Star has made an investment of undisclosed size in air cargo transportation and courier services provider Score Japan Holdings.
Gaorong, Tsing Song back China CDMO IntellectiveBio
Gaorong Capital and Tsing Song Capital have led a CNY 500m (USD 74m) Series C for IntellectiveBio, a China-based contract development and manufacturing organisation (CDMO).
Morningside joins round for China's Epigenic Therapeutics
Morningside Venture Capital has teamed up with Kingray Capital, Trinity Innovation Fund, TigerYeah Capital, and FountainBridge Capital to provide USD 20m in angel and pre-Series A funding for Epigenic Therapeutics, a China-based gene editing specialist.
India fintech app Dezerv raises $21m Series A
Accel has led a USD 21m Series A round for Indian retail investment services app Deserv with support from existing investors Elevation Capital and Matrix Partners India.
Carlyle CEO Kewsong Lee steps down
Kewsong Lee has resigned as CEO of The Carlyle Group just over two years since assuming the role on a solo basis, with co-founder Bill Conway taking over in an interim capacity.
New Zealand's GreenMount seeks $69m for co-investment fund
GreenMount Capital, an investment unit of New Zealand-based GreenMount Advisory, is looking to raise up to NZD 100m (USD 69.2m) for its debut private equity co-investment fund that will participate in deals in Australia and New Zealand.
Australia's Genesis makes biolabs investment
Genesis Capital, a mid-market Australian private equity firm specialising in healthcare, has acquired a majority stake in Crux Biolabs, a contract research organisation (CRO) based in the Melbourne suburbs.
Ex-EQT partner wins funding for Asia ESG services platform
Tak Wai Chung, who until early last year was a Singapore-based partner at EQT, has secured funding for a pan-Asian platform that will provide software solutions to corporates that need to meet environment, social, and governance (ESG) requirements.
Adamantem to carve out cardiology unit from Australia's GenesisCare
Adamantem Capital has agreed to acquire Australia’s largest cardiology services provider through as a carve-out from KKR-backed healthcare giant GenesisCare.
Thailand's SCB 10X appoints Mukaya Panich as CEO
SCB 10X, the VC arm of Thailand’s Siam Commercial Bank, has appointed Mukaya Panich, its chief investment and venture officer, as CEO.
China biotech company GluBio raises $22m
China and US-based GluBio Therapeutics, which develops targeted protein degradation (TPD) drugs, has raised an extended Series A round of USD22m led by Qiming Venture Partners.
Uber, Tiger make Zomato realisations
Uber has fully exited its stake in India-based food services platform Zomato, which completed a domestic IPO just over 12 months ago, while Tiger Global has sold down part of its position.
India's WebEngage gets $20m Series B
Singularity Growth Opportunities Fund and SWC Global have led a USD 20m Series B round for WebEngage, an India-based start-up specialising in customer retention and relationship management.
Japan satellite data, metaverse start-up raises $11m
Japanese VCs have provided a JPY 1.4bn (USD 11m) seed round for SpaceData, a start-up that uses earth imaging data from satellites to create virtual 3D environments replicating the real world.
Proparco commits $25m to India's Northern Arc
French development finance institution Proparco has invested USD 25m in debt in India’s Northern Arc Capital, a microfinance and small business lender with several private equity backers.
Australia hydrogen player gets $29m Series A
Australia’s Virescent Ventures, a VC firm spun out earlier this year from Clean Energy Finance Corporation (CEFC), has led a AUD 40m (USD 29m) Series A round for local hydrogen energy start-up Hysata.
ADIA, GIC lead $300m round for China's Taibang Biologic
Taibang Biologic Group, a specialist in blood plasma-based pharmaceuticals formerly known as China Biologic Products, has raised a USD 300m round led by Abu Dhabi Investment Authority (ADIA) and GIC.